Neurotransmitters of the non-adrenergic non-cholinergic relaxation of proximal stomach

European Review for Medical and Pharmacological Sciences

Volumn 12, Issue SUPPL. 1, 2008, Pages 53-62

  Currò, Diego ^a   Ipavec, V ^a   Preziosi, P ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Adenosine triphosphate (ATP); Apamin; Nitric oxide (NO); Non adrenergic non cholinergic (NANC); Peptide histidine isoleucine (PHI); Relaxation; Vasoactive intestinal polypeptide (VIP)

Indexed keywords

ADENOSINE TRIPHOSPHATE; NEUROTRANSMITTER; NITRIC OXIDE; PEPTIDE DERIVATIVE; VASOACTIVE INTESTINAL POLYPEPTIDE;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; EVOKED RESPONSE; HUMAN; HYPERPOLARIZATION; MOTONEURON; MUSCLE EXCITATION; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NITRERGIC NERVE; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PEPTIDERGIC NERVOUS SYSTEM; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REFRACTORY PERIOD; REVIEW; SENSORY STIMULATION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; SMOOTH MUSCLE TONE; STOMACH MOTILITY; STOMACH MUSCLE; STOMACH PRESSURE; VAGUS NERVE STIMULATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; AUTONOMIC NERVOUS SYSTEM; HUMANS; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; STOMACH; VASOACTIVE INTESTINAL PEPTIDE;

EID: 53249115704     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. LANGLEY JN. On inhibitory fibres in the vagus for the end of the oesophagus and the stomach. J Physiol 1898; 23: 407-414.
2. MCSWINEY BA, ROBSON JM. The response of smooth muscle to stimulation of the vagus nerve. J Physiol 1929; 68: 124-131.
3. AMBACHE N. Unmasking, after cholinergic paralysis by botulinum toxin, of a reversed action of nicotine on the mammalian intestine, revealing the probable presence of local inhibitory ganglion cells in the enteric plexus. Br J Pharmacol Chemother 1951; 6: 51-67.
4. PATON WDM, VANE JR. An analysis of the responses of the isolated stomach to electrical stimulation and to drugs. J Physiol 1963; 165: 10-46.
5. BURNSTOCK G, CAMPBELL G, BENNETT M, HOLMAN ME. Inhibition of the smooth muscle of the taenia coli. Nature 1963; 200: 581-582.
6. BURNSTOCK G, CAMPBELL G, BENNETT M, HOLMAN ME. Innervation of the guinea-pig taenia coli: Are there intrinsic inhibitory nerves which are distinct from sympathetic nerves? Int J Neuropharmacol 1964; 3: 163-166.
7. MARTINSON J. Studies on the efferent vagal control of the stomach. Acta Physiol Scand 1965; 65(Suppl 255): 1-23.
8. BURNSTOCK G. Evolution of the autonomic innervation of visceral and cardiovascular systems in vertebrates. Pharmacol Rev 1969; 21: 247-324.
9. BENNETT MR. Non-adrenergic non-cholinergic (NANC) transmission to smooth muscle: 35 years on. Progr Neurobiol 1997; 52: 159-195.
10. BOECKXSTAENS GE, PELCKMANS PA. Nitric oxide and the non-adrenergic non-cholinergic neurotransmission. Comp Biochem Physiol 1997; 118A: 925-937.
11. TODA N, HERMAN AG. Gastrointestinal function regulation by nitrergic efferent nerves. Pharmacol Rev 2005; 57: 315-338.
12. FAHRENKRUG J. Transmitter role of vasoactive intestinal peptide. Pharmacol Toxicol 1993; 72: 354-363.
13. SHUTTLEWORTH CWR, KEEF KD. Roles of peptides in enteric neuromuscular transmission. Regul Pept 1995; 56: 101-120.
14. BURNSTOCK G, SATCHELL DG, SMYTHE A. A comparison of the excitatory and inhibitory effects of non-adrenergic, non-cholinergic nerve stimulation and exogenously applied ATP on a variety of smooth muscle preparations from different vertebrate species. Br J Pharmacol 1972; 46: 234-242.
15. BURNSTOCK G. The non-adrenergic non-cholinergic nervous system. Arch Int Pharmacodyn 1986; 280(Suppl): 1-15.
16. CURRÒ D, PREZIOSI P. Non-adrenergic non-cholinergic relaxation of the rat stomach. Gen Pharmacol 1998; 31: 697-703.
17. BURNSTOCK G. Purinergic nerves. Pharmacol Rev 1972; 24: 509-581.
18. BURNSTOCK G, CAMPBELL G, SATCHELL DG, Smythe A. Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol 1970; 40: 668-688.
19. HEAZELL MA. Is ATP an inhibitory neurotransmitter in the rat stomach? Br J Pharmacol 1975; 55: 285P-286P.
20. LEFEBVRE RA. Study on the possible neurotransmitter of the non-adrenergic non-cholinergic innervation of the rat gastric fundus. Arch Int Pharmacodyn 1986; 280(Suppl): 110-136.
21. LEFEBVRE RA, BURNSTOCK G. Effect of adenosine triphosphate and related purines in the rat gastric fundus. Arch Int Pharmacodyn 1990; 303: 199-215.
22. BELAI A, LEFEBVRE RA, BURNSTOCK G. Motor activity and neurotransmitter release in the gastric fundus of streptozotocin-diabetic rats. Eur J Pharmacol 1991; 194: 225-234.
23. LEFEBVRE RA, DE BEURME FA, SAS S. Effect of apamin on the response to VIP, ATP and NANC neurone stimulation in the rat and cat gastric fundus. J Auton Pharmacol 1991; 11: 73-83.
24. JENKINSON KM, REID JJ. Evidence that adenosine 5′-triphosphate is the third inhibitory non-adrenergic non-cholinergic neurotransmitter in the rat gastric fundus. Br J Pharmacol 2000; 130: 1627-1631.
25. JENKINSON KM, REID JJ. The P2-purinoceptor antagonist suramin is a competitive antagonist at vasoactive intestinal peptide receptors in the rat gastric fundus. Br J Pharmacol 2000; 130: 1632-1638.
26. CURRÒ D, DE MARCO T, PREZIOSI P. Evidence for an apamin-sensitive, but not purinergic, component in the nonadrenergic noncholinergic relaxation of the rat gastric fundus. Br J Pharmacol 2004; 143: 785-793.
27. HUIZINGA JD, DEN HERTOG A. Inhibition of fundic strips from guinea-pig stomach: The effect of theophylline on responses to adenosine, ATP and intramural nerve stimulation. Eur J Pharmacol 1980; 63: 259-265.
28. HUIZINGA JD, PIELKENROOD JM, DEN HERTOG A. Dual action of high energy adenine nucleotides in comparison with responses evoked by other adenine derivatives and intramural nerve stimulation on smooth muscle. Eur J Pharmacol 1981; 74: 175-180.
29. FREW R, LUNDY PM. Evidence against ATP being the nonadrenergic, noncholinergic inhibitory transmitter in guinea pig stomach. Eur J Pharmacol 1982; 81: 333-336.
30. GRIDER JR, CABLE MB, SAID SI, MAKHLOUF GM. Vasoactive intestinal peptide as a neural mediator of gastric relaxation. Am J Physiol 1985; 248: G73-G78.
31. SELEMIDIS S, COCKS TM. Nitrergic relaxation of the mouse gastric fundus is mediated by cyclic GMP-dependent and ryanodine-sensitive mechanism. Br J Pharmacol 2000; 129: 1315-1322.
32. GIARONI C, KNIGHT GE, RUAN HZ, GLASS R, BARDINI M, LECCHINI S, FRIGO G, BURNSTOCK G. P2 receptors in the murine gastrointestinal tract. Neuropharmacology 2002; 43: 1313-1323.
33. MULÈ F, SERIO R. NANC inhibitory neurotransmission in mouse isolated stomach: Involvement of nitric oxide, ATP and vasoactive intestinal polipeptide. Br J Pharmacol 2003; 140: 431-437.
34. MULÈ F, NACCARI D, SERIO R. Evidence for the presence of P2Y and P2X receptors with different functions in mouse stomach. Eur J Pharmacol 2005; 513: 135-140.
35. BECK K, CALAMAI F, STADERINI G, SUSINI T. Gastric motor responses elicited by vagal stimulation and purine compounds in the atropine-treated rabbit. Br J Pharmacol 1988; 94: 1157-1166.
36. LEFEBVRE RA, WILLEMS JL. Gastric relaxation by apomorphine and ATP in the conscious dog. 1979; 31: 561-563.
37. SAKAI Y, DANIEL EE. Multiple responses to electrical field stimulation in circular muscle of canine gastric corpus. Can J Physiol Pharmacol 1984; 62: 912-918.
38. BURNSTOCK G, COCKS T, PADDLE B, STASZEWSKA-BARCZAK J. Evidence that prostaglandin is responsible for the rebound contraction following stimulation of non-adrenergic, non-cholinergic (purinergic) inhibitory nerves. Eur J Pharmacol 1975; 31: 360-362.
39. HUNT WB, PARSONS DG, WAHID A, WILKINSON J. Influence of 2-2′-pyridylisatogen tosylate on responses produced by ATP and by neural stimulation on the rat gastric corpus. Br J Pharmacol 1978; 63: 378P-379P.
40. KAMATA K, SAKAMOTO A, KASUYA Y. Similarities between the relaxations induced by vasoactive intestinal peptide and by stimulation of the non-adrenergic non-cholinergic neurons in the rat stomach. Naunyn-Schmiedeb Arch Pharmacol 1988; 338: 401-406.
41. ITO S, KUROKAWA A, OHGA A, OHTA T, SAWABE K. Mechanical, electrical and cyclic nucleotide responses to peptide VIP and inhibitory nerve stimulation in rat stomach. J Physiol 1990; 430: 337-353.
42. OKWUASABA FK, HAMILTON JT, COOK MA. Relaxations of guinea-pig fundic strip by adenosine, adenine nucleotides and electrical stimulation: Antagonism by theophylline and desensitization to adenosine and its derivatives. Eur J Pharmacol 1977; 46: 181-198.
43. BAER HP, FREW R. Relaxation of guinea-pig fundic strip by adenosine, adenosine triphosphate and electrical stimulation: Lack of antagonism by theophylline or ATP treatment. Br J Pharmacol 1979; 67: 293-299.
44. COSTA M, FURNESS JB, HUMPHREYS CMS. Apamin distinguishes two types of relaxation mediated by enteric nerves in the guinea-pig gastrointestinal tract. Naunyn-Schmiedeberg's Arch Pharmacol 1986; 332: 79-88.
45. OHNO N, XUE L, YAMAMOTO Y, SUZUKI H. Properties of the inhibitory junction potential in smooth muscle of the guinea-pig gastric fundus. Br J Pharmacol 1996; 117: 974-978.
46. ANDREWS PLR, LAWES INC. Characteristic of the vagally driven non-adrenergic, non-cholinergic inhibitory innervation of ferret gastric corpus. J Physiol 1985; 363: 1-20.
47. SAID SI, MUTT V. Polypeptide with broad biological activity: isolation from small intestine. Science 1970; 169: 1217-1218.
48. BRYANT MG, POLAK JM, MODLIN I, BLOOM SR, ALBUQUERQUE RH, Pearse AGE. Possible dual role for vasoactive intestinal peptide as a gastrointestinal hormone and neurotransmitter substance. Lancet 1976; i: 991-993.
49. LARSSON LI, FAHRENKRUG J, SCHAFFALITZKY DE MUCKADELL O, SUNDLER F, HAKANSON R, REHFELD JB. Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons. Proc Natl Acad Sci USA 1976; 73: 3197-3200.
50. TATEMOTO K, MUTT V. Isolation and characterization of the intestinal peptide porcine PHI (PHI-27), a new member of the glucagon-secretin family. Proc Natl Acad Sci USA 1981; 78: 6603-6607.
51. CURRÒ D, PREZIOSI P, RAGAZZONI E, CIABATTONI G. Peptide histidine isoleucine-like immunoreactivity release from the rat gastric fundus. Br J Pharmacol 1994; 113: 541-549.
52. CAUVIN A, VANDERMEERS A, VANDERMEERS-PIRET MC, ROBBERECHT P, CHRISTOPHE J. Variable distribution of three molecular forms of peptide histidine isoleucinamide in rat tissues: Identification of the large molecular form as peptide histidine valine-(1-42). Endocrinology 1989; 125: 2645-2655.
53. D'AMATO M, CURRÒ D, CIABATTONI G, LEFEBVRE RA. Is peptide histidine isoleucine an inhibitory nonadrenergic noncholinergic neurotransmitter in the rat gastric fundus? Arch Int Pharmacodyn 1990; 303: 216-231.
54. LEFEBVRE RA, SAS S, CAUVIN A. Relaxant eftect of rat PHI, PHI-Gly and PHV (1-42) in the rat gastric fundus. Peptides 1991; 12: 271-274.
55. CURRÒ D, DE MARCO T, PREZIOSI P. Involvement of peptide histidine isoleucine in non-adrenergic non-cholinergic relaxation of the rat gastric fundus induced by high-frequency neuronal firing. Naunyn-Schmiedeberg's Arch Pharmacol 2002; 366: 578-586.
56. D'AMATO M, CURRÒ D, MONTUSCHI P, CIABATTONI G, RAGAZZONI E, LEFEBVRE RA. Release of vasoactive intestinal polypeptide from the rat gastric fundus. Br J Pharmacol 1992; 105: 691-695.
57. DESAI KM, WARNER TD, BISHOP AE, POLAK JM, VANE JR. Nitric oxide, and not vasoactive intestinal peptide, as the main neurotransmitter of vagally induced relaxation of the guinea pig stomach. Br J Pharmacol 1994; 113: 1197-1202.
58. DICK JMC, VAN GELDRE LA, TIMMERMANS JP, LEFEBVRE RA. Investigation of the interaction between nitric oxide and vasoactive intestinal polypeptide in the guinea-rig gastric fundus. Br J Pharmacol 2000; 129:751-763.
59. BACCARI MC, CALAMAI F. Modulation of nitrergic relaxant responses by peptides in the mouse gastric fundus. Regul Pept 2001; 98: 27-32.
60. DICK JM, VAN MOLLE W, BROUCKAERT P, LEFEBVRE RA. Relaxatipn by vasoactive intestinal polypeptide in the gastric fundus of nitric oxide synthase-deficient mice. J Physiol 2002; 538: 133-143.
61. FAHRENKRUG J, HAGLUND U, JODAL M, LUNDGREN O, OLBE L, DE MUCKADELL OB . Nervous release of vasoactive intestinal polypeptide in the gastrointestinal tract of cats: Possible physiological implications. J Physiol 1978; 284: 291-305.
62. D'AMATO M, DE BEURME FA, LEFEBVRE RA. Comparison of the effect of vasoactive intestinal polypeptide and non-adrenergic non-cholinergic neurone stimulation in the cat gastric fundus. Eur J Pharmacol 1988; 152: 71-82.
63. MERLO A, COHEN S. Vasoactive intestinal peptide. An inhibitor of feline gastric smooth muscle in vitro. Dig Dis Sci 1989; 34: 1365-1368.
64. CHERNAEVA L. Nitrergic and peptidergic components of NANC relaxations of cat gastric fundus. Acta Physiol Pharmacol Bulg 2000; 25: 27-31.
65. ITO S, OHGA A, OHTA T. Gastric vasodilatation and vasoactive intestinal peptide output in response to vagal stimulation in the dog. J Physiol 1988; 404: 669-682.
66. OHTA T, ITO S, OHGA A. Co-release of PHI and VIP in dog stomach by peripheral and central vagal stimulation. Br J Pharmacol 1990; 100: 231-236.
67. BAYGUINOV O, KEEF KD, HAGEN B, SANDERS KM. Parallel pathways mediate inhibitory effects of vasoactive intestinal polypeptide and nitric oxide in canine fundus. Br J Pharmac 1999; 126: 1543-1552.
68. MANDREK K, MILENOV K. Responses of porcine gastric and duodenal smooth muscle to VIP. J Auton Pharmacol 1991; 11: 353-364.
69. LEFEBVRE RA, SMITS GJ, TIMMERMANS JP. Study of NO and VIP as non-adrenergic non-cholinergic neurotransmitters in the pig gastric fundus. Br J Pharmacol 1995; 116: 2017-2026.
70. DICK JMC, LEFEBVRE RA. Interplay between nitric oxide and vasoactive intestinal polypeptide in the pig gastric fundus smooth muscle. Eur J Pharmacol 2000; 397: 389-397.
71. BACCARI MC, CALAMAI F, STADERINI G. Non-adrenergic, non-cholinergic influences on rabbit gastric tone. Funct Neurol 1990; 5: 197-199.
72. TONINI M, DE GIORGIO R, DE PONTI F, STERNINI C, SPELTA V, DIONIGI P, BARBARA G, STANGHELLINI V, CORINALDESI R. Role of nitric oxide- and vasoactive intestinal polypeptide-containing neurones in human gastric fundus strip relaxations. Br J Pharmacol 2000; 129: 12-20.
73. TAKAHASHI T, OWYANG C. Vagal control of nitric oxide and vasoactive intestinal polypeptide release in the regulation of gastric relaxation in rat. J Physiol 1995; 484: 481-492.
74. DE BEURME FA, LEFEBVRE RA. Influence of alpha-chymotrypsin and trypsin on the non-adrenergic non-cholinergic relaxation in the rat gastric fundus. Br J Pharmacol 1987; 91: 171-177.
75. D'AMATO M, CURRÒ D, MONTUSCHI P. Evidence for dual components in the non-adrenergic non-cholinergic relaxation in the rat gastric fundus: Role of endogenous nitric oxide and vasoactive intestinal polypeptide. J Auton Nerv Syst 1992; 37: 175-186.
76. BOECKXSTAENS GE, PELCKMANS PA, DE MAN JG, BULT H, HERMAN AG, VAN MAERCKE YM. Evidence for a differential release of nitric oxide and vasoactive intestinal polypeptide by nonadrenergic non-cholinergic nerves in the rat gastric fundus. Arch Int Pharmacodyn 1992; 318: 107-115.
77. SMITS GJ, LEFEBVRE RA. Development of cholinergic and inhibitory non-adrenergic non-cholinergic responses in the rat gastric fundus. Br J Pharmacol 1996; 118: 1987-1994.
78. DE BEURME FA, LEFEBVRE RA. Vasoactive intestinal polypeptide as possible mediator of relaxation in the rat gastric fundus. J Pharm Pharmacol 1988; 40: 711-715.
79. LI CG, RAND MJ. Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur J Pharmacol 1990; 191: 303-309.
80. LEFEBVRE RA, BAERT E, BARBIER AJ. Influence of NG-nitro-L-arginine on non-adrenergic non-cholinergic relaxation in the guinea-pig gastric fundus. Br J Pharmacol 1992; 106: 173-179.
81. BARBIER AJ, LEFEBVRE RA. Involvement of the L-arginine: nitric oxide pathway in nonadrenergic non-cholinergic relaxation of the cat gastric fundus. J Pharmacol Exp Ther 1993; 266: 172-178.
82. PALMER RM, FERRIGE AG, MONCADA S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
83. GILLESPIE JS, LIU XR, MARTIN W. The effects of L-arginine and NG-monomethyl L-arginine on the response of the rat anococcygeus muscle to NANC nerve stimulation. Br J Pharmacol 1989; 98: 1080-1082.
84. ALDERTON WK, COOPER CE, KNOWLES RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357: 593-615.
85. BOECKXSTAENS GE, PELCKMANS PA, ROGERS JJ, BULT H, DE MAN JG, OOSTERBOSCH L, HERMAN AG, VAN MAERCKE YM. Release of nitric oxide upon stimulation of non-adrenergic noncholinergic nerves in the rat gastric fundus. J Pharmacol Exp Ther 1991; 256: 441-447.
86. DE MAN JG, MOREELS TG, DE WINTER BY, HERMAN AG, PELCKMANS PA. Pre- and postjunctional protective effect of neocuproine on the nitrergic neurotransmitter in the mouse gastric fundus. Br J Pharmacol 2001; 132: 277-285.
87. LEFEBVRE RA. Influence of a selective guanylate cyclase inhibitor, and of the contraction level, on nitrergic relaxations in the gastric fundus. Br J Pharmacol 1998; 124: 1439-1448.
88. SHIMAMURA K, FUJISAWA A, TODA N, SUNANO S. Effects of NG-nitro-L-arginine on electrical and mechanical responses to stimulation of non-adrenergic, non-cholinergic inhibitory nerves in circular muscle of the rat gastric fundus. Eur J Pharmacol 1993; 231: 103-109.
89. KAMATA K, KOHZUKI M, MISAWA M, KASUYA Y. Involvement of nitric oxide pathway in non-adrenergic non-cholinergic (NANC) relaxation in the rat stomach: Differential innervation of NANC nerves in the longitudinal and circular muscle of the fundus. Gen Pharmac 1993; 24: 1403-1410.
90. MCLAREN A, LI CG, RAND MJ. Mediators of nicotine-induced relaxations of the rat gastric fundus. Clin Exp Pharmacol Physiol 1993; 20: 451-457.
91. HOLZER-PETSCHE U, MOSER R. Participation of nitric oxide in the relaxation of the rat gastric corpus. Naunyn-Schmiedeberg's Arch Pharmacol 1996; 354: 348-354.
92. TAKAHASHI T, OWYANG C. Characterization of vagal pathways mediating gastric accomodation reflex in rats. J Physiol 1997; 504: 479-488.
93. LEFEBVRE RA, HASRAT J, GOBERT A. Influence of NG-nitro-L -arginine methyl ester on vagally induced gastric relaxation in the anaesthetized rat. Br J Pharmacol 1992; 105: 315-320.
94. DESAI KM, SESSA WC, VANE JR. Involvement of nitric oxide in the reflex relaxation of the stomach to acomodate food or fluid. Nature 1991; 351: 477-479.
95. DESAI KM, ZEMBOWICS A, SESSA WC, VANE JR. Nitroxergic nerves mediate vagally induced relaxation in the isolated stomach of the guinea pig. Proc Natl Acad sci USA 1991; 88: 11490-11494.
96. DE MAN JG, DE WINTER BY, HERMAN AG, PELCKMANS PA. Study on the cyclic GMP-dependency of relaxations to endogenous and exogenous nitric oxide in the mouse gastrointestinal tract. Br J Pharmacol 2007; 150: 88-96.
97. CURRÒ D, VOLPE AR, PREZIOSI P. Nitric oxide synthase activity and non-adrenergic non-cholinergic relaxation in the rat gastric fundus. Br J Pharmacol 1996; 117: 717-723.